The subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for pain.
Clinical Journal of Pain June 2014 Mohammed A Issa, Sanjeet Narang, Robert N. Jamison et al.
Many cannabinoid medications are approved in North America or in phase III trials, such as dronabinol, nabilone, or nabiximols. Little is known about their subjective psychoactive effects when used for pain management. We hypothesized that when used for pain, dronabinol has psychoactive effects in a dose-response relationship, whose peak effects are comparable with smoking marijuana. This was a...